Baker Heart and Diabetes Institute
Melbourne, Victoria 3004
3 studies enrolling now · 12 studies all time
What they study most
Antineoplastics Toxicity, Cancer, Cardiac Toxicity, Cardiotoxicity, Cardiovascular Disease, Diabetes, Diabetes Mellitus, Type 2, Diabetic Cardiomyopathies, Heart Failure, Obesity, Overweight, Resistant Hypertension
Studies at this site
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes — Recruiting now
- The STOP-MED CTRCD Trial — Recruiting now
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight — Completed
- Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes — Running, not enrolling
- Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study — Enrolling by invitation
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight — Completed
- Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus — Completed
- A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety — Completed
- Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy — Running, not enrolling
- A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. — Completed